Premium
FDA, responding to critics, to look at restricting opioids for pain
Publication year - 2016
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30113
Subject(s) - food and drug administration , agency (philosophy) , opioid , administration (probate law) , business , medicine , advertising , political science , medical emergency , law , sociology , social science , receptor
The Food and Drug Administration (FDA) has announced that it will reassess the way it approaches approvals for opioid medications. On February 5, Robert Califf, M.D., the deputy commissioner for medical products and tobacco, announced that the agency would take a harder line against opioids.